WallStSmart
ABOS

Acumen Pharmaceuticals Inc

NASDAQ: ABOS · HEALTHCARE · BIOTECHNOLOGY

$2.34
-4.88% today

Updated 2026-04-29

Market cap
$169.01M
P/E ratio
P/S ratio
538.78x
EPS (TTM)
$-2.00
Dividend yield
52W range
$1 – $4
Volume
0.6M

Acumen Pharmaceuticals Inc (ABOS) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
+4.0%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
+33.9%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-1.8%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
-8.1%
2025-11-12
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-30$-0.41+10.0%$2.26$2.36+4.4%
2025-11-12$-0.44+27.0%$1.97$1.81-8.1%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.46$-0.41+10.0%
2025-09-30$-0.60$-0.44+27.0%
2025-06-30$-0.51$-0.68-33.3%
2025-03-31$-0.55$-0.48+12.1%
2024-12-31$-0.37$-0.62-69.5%$178000.00-38.6%
2024-09-30$-0.36$-0.50-37.6%
2024-06-30$-0.28$-0.34-21.4%
2024-03-31$-0.26$-0.25+3.8%
2023-12-31$-0.26$-0.28-7.7%$290000.00
2023-09-30$-0.27$-0.24+11.1%
2023-06-30$-0.35$-0.28+20.0%
2023-03-31$-0.35$-0.28+20.0%

Frequently asked questions

Has Acumen Pharmaceuticals Inc beaten earnings estimates?
Acumen Pharmaceuticals Inc has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports, with an average EPS surprise of +4.0% over the last 4 quarters.
How does ABOS stock react to earnings?
ABOS stock has moved an average of -1.8% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.